Risperdal® is an anti-psychosis drug approved by the US Food and Drug Administration to treat schizophrenia in adults. However, the manufacturer of Risperdal®, Johnson & Johnson, marketed the drugs off-label as a treatment for behavioral disorders in children. Marketing a pharmaceutical drug off-label is already pretty bad. Marketing a pharmaceutical drug off-label to children is a bit worse. But what happens when a company hides the side effects of a drug on children that you’re marketing off-label to children?
Steven Brill, a health care journalist and attorney, has investigated the case of Risperdal® and is sharing his results in a 15-chapter, in-depth exposé. The very long story is, in short, an amazing tale of the decisions made by a pharmaceutical drug company in the pursuit of money. The exposé, titled “America’s Most Admired Lawbreaker”, has been released one chapter a day on The Huffington Post. Chapter 14 was released today.
If you’ve ever wanted insight into why a gigantic corporation would go out of its way to knowingly push a dangerous drug, this is your chance. Read America’s Most Admired Lawbreaker. If you or a loved one has ever been harmed by a dangerous drug, contact The Law Offices of Larry H. Parker at (800) 333-0000 for a free legal consultation.
